Indian J Psychiatry. 2025 Apr;67(4):432-435. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_603_24. Epub 2025 Apr 15.ABSTRACTBACKGROUND: Type 1 Diabetes mellitus (T1DM) is a common chronic disorder, among the children and adolescents, posing both physical and psychological challenges.AIMS: To asse
Cureus. 2025 Apr 13;17(4):e82202. doi: 10.7759/cureus.82202. eCollection 2025 Apr.ABSTRACTObjective Diabetic nephropathy (DN) is the most common microvascular complication in type 1 diabetes mellitus (T1DM). The study aimed to assess the role of renal resistive index (RRI) in early detection of DN i
JCEM Case Rep. 2025 May 14;3(6):luaf100. doi: 10.1210/jcemcr/luaf100. eCollection 2025 Jun.ABSTRACTGlycogenic hepatopathy (GH) is a rare clinical entity characterized by glycogen accumulation in the liver which affects a minority of patients with poorly controlled diabetes mellitus. Its cardinal man
Front Immunol. 2025 Apr 30;16:1567874. doi: 10.3389/fimmu.2025.1567874. eCollection 2025.ABSTRACTChromogranin A (CgA), mostly known as a nonspecific neuroendocrine tumor marker, was the first glycoprotein from the granin family characterized as a prohormone for various bioactive peptides including v
Eur J Ophthalmol. 2025 May 14:11206721251341596. doi: 10.1177/11206721251341596. Online ahead of print.ABSTRACTIntroductionDiabetic retinopathy (DR) is a blindness-causing disease which belongs to the group of neurodegenerative diseases. Neurodegeneration of the retina is a process, in which retinal
Diabetes Res Clin Pract. 2025 May 12:112245. doi: 10.1016/j.diabres.2025.112245. Online ahead of print.ABSTRACTBACKGROUND: The 2019 European Society of Cardiology and European Association for the Study of Diabetes (ESC/EASD) recommendations classified cardiovascular disease (CVD) risk in diabetes me
No abstractDiabetes Metab J. 2025 May;49(3):516-517. doi: 10.4093/dmj.2025.0243. Epub 2025 May 1.NO ABSTRACTPMID:40367994 | DOI:10.4093/dmj.2025.0243
No abstractDiabetes Metab J. 2025 May;49(3):520-521. doi: 10.4093/dmj.2025.0282. Epub 2025 May 1.NO ABSTRACTPMID:40367992 | DOI:10.4093/dmj.2025.0282
J Peripher Nerv Syst. 2025 Jun;30(2):e70026. doi: 10.1111/jns.70026.ABSTRACTBACKGROUND: Hyperglycemia is a major driver of diabetic peripheral neuropathy (DPN) in type 1 diabetes mellitus (T1DM). Advanced hybrid closed-loop (AHCL) technologies improve glycemic control and reduce glycemic variability
Avicenna J Phytomed. 2025 May-Jun;15(3):1124-1136. doi: 10.22038/ajp.2024.24986.ABSTRACTOBJECTIVE: Although there are many drugs on the shelves of pharmacies to manage diabetes mellitus (DM), many people around the world still use herbal preparations to treat it. This study investigated the effect o
Int J Mol Sci. 2025 Apr 26;26(9):4120. doi: 10.3390/ijms26094120.ABSTRACTInflammation of the exocrine pancreas accompanies autoimmune diabetes in mouse models and humans. However, the relationship between inflammation in the exocrine and endocrine (islet) compartments has not been explored. To addre
Int J Mol Sci. 2025 Apr 22;26(9):3935. doi: 10.3390/ijms26093935.ABSTRACTType 1 diabetes (T1D) is an autoimmune condition characterized by the destruction of insulin-producing pancreatic beta cells, leading to lifelong insulin dependence and significant complications. Early detection of T1D is essen
CONCLUSION: This ^(31)P-MRS ST method allowed for robust assessment of hepatic ATP synthesis at clinical field strength and was sensitive enough to detect differences between CON and T1D volunteers.Eur Radiol Exp. 2025 May 13;9(1):51. doi: 10.1186/s41747-025-00588-9.ABSTRACTBACKGROUND: 31P-magnetic
Nat Rev Endocrinol. 2025 May 13. doi: 10.1038/s41574-025-01125-9. Online ahead of print.ABSTRACTThe identification of amylin as a glucoregulatory peptide hormone with roles in meal-ending satiation sparked a surge of experimental development, which culminated in the amylin mimetic drug pramlintide.
PLoS One. 2025 May 13;20(5):e0323642. doi: 10.1371/journal.pone.0323642. eCollection 2025.ABSTRACTBACKGROUND: Type 1 diabetes (T1D) is an autoimmune condition characterized by the destruction of insulin-producing beta cells in the pancreas. Anti-Thymocyte Globulin (ATG) has emerged as a promising im
Front Endocrinol (Lausanne). 2025 Apr 28;16:1456641. doi: 10.3389/fendo.2025.1456641. eCollection 2025.ABSTRACTINTRODUCTION: Every one in seven people with Type-I or Type-II diabetes suffers from fear of hypoglycemia (FOH). Its impact on quality of life, glycemic control, and health outcomes is well
Front Endocrinol (Lausanne). 2025 Apr 28;16:1533748. doi: 10.3389/fendo.2025.1533748. eCollection 2025.ABSTRACTType 1 diabetes (T1D) arises from an autoimmune attack on pancreatic beta cells, leading to a reliance on external insulin to maintain glucose levels. In recent years, research has increasi
Food Res Int. 2025 Jun;211:116502. doi: 10.1016/j.foodres.2025.116502. Epub 2025 Apr 21.ABSTRACTSince type 2 diabetic patients often develop resistance to metformin as the progresses of diabetes, and almost all type 1 diabetic patients need receive insulin injection for hyperglycemia control. It is
Medicine (Baltimore). 2025 May 9;104(19):e42430. doi: 10.1097/MD.0000000000042430.ABSTRACTThis study aims to explore whether bilirubin can act as a biomarker of oxidative stress in type 1 diabetes mellitus (T1DM) by analyzing the serum bilirubin levels and possible influencing factors in different d
Medicine (Baltimore). 2025 May 9;104(19):e42453. doi: 10.1097/MD.0000000000042453.ABSTRACTDiabetic ketoacidosis (DKA) poses a significant risk to diabetic pediatric patients, warranting effective management strategies to prevent complications. Current DKA management protocols often use normal saline
Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07495-0. Online ahead of print.ABSTRACTDiabetes is associated with an increased risk of fracture. Areal bone mineral density (aBMD), the most reliable indicator of fracture risk in healthy adults, is low in patients with type 1 diabetes mellitus b
Pediatr Nephrol. 2025 May 12. doi: 10.1007/s00467-025-06793-3. Online ahead of print.ABSTRACTBACKGROUND: Uncontrolled diabetes mellitus (DM) accelerates atherosclerosis and vascular diseases, leading to micro- and macrovascular complications. Early cardiac and kidney involvement necessitates an earl
Pediatr Endocrinol Diabetes Metab. 2025;31(1):9-16. doi: 10.5114/pedm.2025.149201.ABSTRACTINTRODUCTION: Diabetes is undeniably a pandemic of the 21st century. Although type 1 diabetes mellitus (T1DM) only represents 10% of all diabetes cases, it dominates the pediatric population. The number of T1DM
Pediatr Endocrinol Diabetes Metab. 2025;31(1):1-8. doi: 10.5114/pedm.2025.148400.ABSTRACTINTRODUCTION: Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin i
